NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.45+0.30 (+13.95%)
Close on Nov 17, 2026Market cap $106.07MP/E –Yield –
NRX Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NRX Pharmaceuticals's enterprise value was $78.62M on Nov 11, 2026, against $60.64M a year earlier. Over the last 5 years it ranged from -$2.92M to $478.97M, with a median of $44.17M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $78.62M | +15.9% |
| 2025 | Dec 31, 2025 | $67.84M | +190.2% |
| 2024 | Dec 31, 2024 | $23.38M | -41.2% |
| 2023 | Dec 29, 2023 | $39.77M | -30.0% |
| 2022 | Dec 30, 2022 | $56.83M | -88.1% |
| 2021 | Oct 29, 2021 | $478.97M | -40.3% |
| 2020 | Dec 31, 2020 | $802.23M | +120.0% |
| 2019 | Dec 31, 2019 | $364.72M | +10.7% |
| 2018 | Dec 31, 2018 | $329.55M | – |
See a number that looks wrong?